AU2002326742B2 - KGF polypeptide compositions - Google Patents
KGF polypeptide compositions Download PDFInfo
- Publication number
- AU2002326742B2 AU2002326742B2 AU2002326742A AU2002326742A AU2002326742B2 AU 2002326742 B2 AU2002326742 B2 AU 2002326742B2 AU 2002326742 A AU2002326742 A AU 2002326742A AU 2002326742 A AU2002326742 A AU 2002326742A AU 2002326742 B2 AU2002326742 B2 AU 2002326742B2
- Authority
- AU
- Australia
- Prior art keywords
- kgf
- amino acid
- inclusive
- acid residues
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2007214362A AU2007214362B2 (en) | 2001-08-21 | 2007-08-31 | KGF polypeptide compositions |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31388101P | 2001-08-21 | 2001-08-21 | |
| US60/313,881 | 2001-08-21 | ||
| PCT/US2002/026929 WO2003016505A2 (en) | 2001-08-21 | 2002-08-21 | Kgf polypeptide compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007214362A Division AU2007214362B2 (en) | 2001-08-21 | 2007-08-31 | KGF polypeptide compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002326742A1 AU2002326742A1 (en) | 2003-05-29 |
| AU2002326742B2 true AU2002326742B2 (en) | 2007-05-31 |
Family
ID=23217561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002326742A Ceased AU2002326742B2 (en) | 2001-08-21 | 2002-08-21 | KGF polypeptide compositions |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7265089B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1429799A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2005500390A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002326742B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2457781A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04001526A (cg-RX-API-DMAC7.html) |
| PL (1) | PL374269A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003016505A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012000865A2 (pt) * | 2009-07-17 | 2019-09-24 | T Tabor Aaron | "composição e método para a modificação genética cosmética de células substancialmente intactas" |
| US20160250298A1 (en) | 2013-11-01 | 2016-09-01 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
| TW201613622A (en) * | 2014-10-14 | 2016-04-16 | Bionet Corp | Composition for skincare and pharmaceutical composition and preparation method thereof |
| CN109402130A (zh) * | 2018-11-23 | 2019-03-01 | 成都中医药大学附属医院 | 一种重组人角质细胞生长因子-1及其制备方法和用途 |
| KR20230127721A (ko) * | 2022-02-25 | 2023-09-01 | 한국해양과학기술원 | 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996011949A2 (en) * | 1994-10-13 | 1996-04-25 | Amgen Inc. | Analogs of keratinocyte growth factor |
| WO1998024813A2 (en) * | 1996-12-06 | 1998-06-11 | Amgen Inc. | Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0555205T3 (da) | 1989-01-31 | 2001-03-05 | Jeffrey S Rubin | DNA, der koder for en væstfaktor, som er specifik for epitelceller |
| US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| US5655870A (en) * | 1993-03-01 | 1997-08-12 | Kawasaki Steel Corporation | Stacker crane in a warehouse |
| US5814605A (en) | 1993-03-26 | 1998-09-29 | Amgen Inc. | Therapeutic uses of keratinocyte growth factor |
| NZ266622A (en) | 1993-06-29 | 1997-10-24 | Chiron Corp | Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates |
| SI0785950T1 (en) | 1994-10-13 | 2003-08-31 | Amgen Inc. | Keratinocyte growth factor analogs |
| DK0785949T3 (da) * | 1994-10-13 | 2003-08-18 | Amgen Inc | Fremgangsmåde til oprensning af keratinocytvækstfaktorer |
| US5841605A (en) * | 1996-11-06 | 1998-11-24 | Iomega Corporation | Caddy for cartridge and disk drive accomodating a caddy |
-
2002
- 2002-08-21 MX MXPA04001526A patent/MXPA04001526A/es active IP Right Grant
- 2002-08-21 US US10/227,185 patent/US7265089B2/en not_active Expired - Fee Related
- 2002-08-21 JP JP2003521814A patent/JP2005500390A/ja active Pending
- 2002-08-21 WO PCT/US2002/026929 patent/WO2003016505A2/en not_active Ceased
- 2002-08-21 EP EP02761479A patent/EP1429799A4/en not_active Withdrawn
- 2002-08-21 CA CA002457781A patent/CA2457781A1/en not_active Abandoned
- 2002-08-21 AU AU2002326742A patent/AU2002326742B2/en not_active Ceased
- 2002-08-21 PL PL02374269A patent/PL374269A1/xx unknown
-
2007
- 2007-04-16 US US11/787,428 patent/US20080200378A1/en not_active Abandoned
-
2009
- 2009-05-18 JP JP2009119866A patent/JP2009221207A/ja not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996011949A2 (en) * | 1994-10-13 | 1996-04-25 | Amgen Inc. | Analogs of keratinocyte growth factor |
| WO1998024813A2 (en) * | 1996-12-06 | 1998-06-11 | Amgen Inc. | Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2457781A1 (en) | 2003-02-27 |
| JP2009221207A (ja) | 2009-10-01 |
| JP2005500390A (ja) | 2005-01-06 |
| US7265089B2 (en) | 2007-09-04 |
| PL374269A1 (en) | 2005-10-03 |
| WO2003016505A2 (en) | 2003-02-27 |
| US20080200378A1 (en) | 2008-08-21 |
| EP1429799A4 (en) | 2005-12-21 |
| MXPA04001526A (es) | 2004-05-31 |
| US20030109439A1 (en) | 2003-06-12 |
| WO2003016505A3 (en) | 2004-01-08 |
| EP1429799A2 (en) | 2004-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1751184B1 (en) | Fgf-21 fusion proteins | |
| AU2005283025B2 (en) | Muteins of fibroblast growth factor 21 | |
| AU646514B2 (en) | Chimeric fibroblast growth factor | |
| JP6181752B2 (ja) | 線維芽細胞増殖因子21変異体 | |
| US20070265200A1 (en) | Glycol Linked Fgf-21 Compounds | |
| CA2232749C (en) | Truncated glial cell line-derived neurotrophic factor | |
| EP1831371A2 (en) | Muteins of fibroblast growth factor 21 | |
| JP2004166709A (ja) | 増加した生物学的活性を有する短縮型ケラチノサイト増殖因子(kgf) | |
| US5736363A (en) | IGF-II analogues | |
| US20080200378A1 (en) | KGF polypeptide compositions | |
| SG185946A1 (en) | Novel neurturin conjugates for pharmaceutical use | |
| AU2002326742A1 (en) | KGF polypeptide compositions | |
| EP1961821B1 (en) | Erythropoietin fusion protein | |
| AU2007214362B2 (en) | KGF polypeptide compositions | |
| EP0668911A1 (en) | Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor | |
| CN1065875C (zh) | 成纤维细胞生长因子-2结构类似物,其生产方法及应用 | |
| CA2079291A1 (en) | Activities of heparin binding neurite-outgrowth promoting factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period | ||
| NB | Applications allowed - extensions of time section 223(2) |
Free format text: THE TIME IN WHICH TO REQUEST EXAMINATION HAS BEEN EXTENDED TO 18 MAR 2006. |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |